Activating the GPR133 receptor with a small molecule can rebuild bone from within, offering a new direction for osteoporosis ...
A recent mouse model based study suggests that blocking TGF-β may improve osteoporosis treatment by helping quiescent osteoblasts in inactive bone surfaces return to an active state. Using spatial ...
"In this study, we established an advanced high-resolution microscopy system to visualize extracellular vesicles secreted and captured by mature osteoblasts in vivo and identified a subset of ...
A recent mouse model based study suggests that blocking TGF-β may improve osteoporosis treatment by helping quiescent ...
Osteoblasts act in a group to make bone over the course of several months. However, how osteoblasts cooperate with each other in vivo is still unknown. Now, researchers at Osaka University established ...
“[...] chlorogenic acid appears to be a promising candidate for the management of osteoporosis.” Osteoporosis is a common bone disease in aging populations ...
In our bones, specialized cells called osteoblasts are responsible for building up bone substance. A team of researchers has now identified an enzyme that controls the activity of osteoblasts. An ...
Pharmacodynamic analysis of receptor tyrosine kinase (RTK) activity reveals differential target inhibition in skin and tumor in a phase I study of advanced colorectal cancer patients treated with ...
Reviewed by Ann Kearns, MD, PhD, associate professor and chair of Quality and Safety in the Division of Endocrinology at the Mayo Clinic in Rochester, Minnesota. "Medical Journeys" is a set of ...
One of the best-documented pathophysiological changes associated with microgravity and the spaceflight environment is bone loss. The reduction in bone mass and its effect following reentry could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results